Investment opportunity is what the others are actively promoting , PAA management need to understand they are competing for Investment $$$.
They need to bring in professional assistance for the Presentation of the MND data..
If the Positive MND data and possibly a K9 Commercial deal don't bring the oppies in the money then a CR will be required again?
With $15m at stake you would think Management would have the Oppies as priority?
MPL has been doing all the Heavy Lifting ... NZT
Ann: MND Biomarkers and Pharmacodynamics Results, page-397
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.020(9.30%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $562.4K | 2.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64065 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 115000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |